A. CİHAN Et Al. , "Reasons of phosphodiesterase type 5 inhibitors patients lapse from follow up," 12th Congress of the International Society for Sexual Medicine , KAHİRE, Egypt, 2006
CİHAN, A. Et Al. 2006. Reasons of phosphodiesterase type 5 inhibitors patients lapse from follow up. 12th Congress of the International Society for Sexual Medicine , (KAHİRE, Egypt).
CİHAN, A., DEMİR, Ö., BOZKURT, O., ÖZDEMİR, İ., & ESEN, A. A., (2006). Reasons of phosphodiesterase type 5 inhibitors patients lapse from follow up . 12th Congress of the International Society for Sexual Medicine, KAHİRE, Egypt
CİHAN, AHMET Et Al. "Reasons of phosphodiesterase type 5 inhibitors patients lapse from follow up," 12th Congress of the International Society for Sexual Medicine, KAHİRE, Egypt, 2006
CİHAN, AHMET Et Al. "Reasons of phosphodiesterase type 5 inhibitors patients lapse from follow up." 12th Congress of the International Society for Sexual Medicine , KAHİRE, Egypt, 2006
CİHAN, A. Et Al. (2006) . "Reasons of phosphodiesterase type 5 inhibitors patients lapse from follow up." 12th Congress of the International Society for Sexual Medicine , KAHİRE, Egypt.
@conferencepaper{conferencepaper, author={AHMET CİHAN Et Al. }, title={Reasons of phosphodiesterase type 5 inhibitors patients lapse from follow up}, congress name={12th Congress of the International Society for Sexual Medicine}, city={KAHİRE}, country={Egypt}, year={2006}}